BCL::Commons Commercial License Quote provides tailored access to this cutting-edge C++ library for biological molecule simulation, enabling for-profit organizations and non-academic users to integrate advanced tools into proprietary workflows for drug discovery and biomolecular research. From Vanderbilt University's Meiler Lab, BCL::Commons offers enterprise-grade capabilities, including protein structure prediction from sparse data, BCL::MolAlign for superior small molecule alignment (excelling in pharmacophore mapping over standard tools), fragment derivation for lead optimization, density map analysis for structural biology, and scalable virtual screening—accelerating innovation in pharmaceuticals and biotech.
- Key Features: High-performance modular architecture; BCL::MolAlign for flexible 3D alignment in ligand-based design; neural network scoring for general-purpose drug discovery; extensible for custom applications in cheminformatics and molecular dynamics.
- Commercial Benefits: Customized licensing for institutional needs, including priority support, integration assistance, and compliance for contract research or product development.
- Usage: For for-profit, non-academic applications; no full-time academic affiliation required—submit details for a personalized quote.
To request a commercial license quote, complete the webform below. A BCL::Commons representative will contact you within 3 - 5 business days to review options and pricing tailored to your organization.